Comerica Bank boosted its stake in Mylan N.V. (NASDAQ:MYL) by 2.9% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 117,928 shares of the company’s stock after buying an additional 3,272 shares during the period. Comerica Bank’s holdings in Mylan N.V. were worth $4,571,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the company. Cleararc Capital Inc. boosted its position in shares of Mylan N.V. by 0.6% in the first quarter. Cleararc Capital Inc. now owns 10,394 shares of the company’s stock valued at $405,000 after buying an additional 67 shares in the last quarter. Conning Inc. boosted its position in shares of Mylan N.V. by 1.3% in the first quarter. Conning Inc. now owns 10,128 shares of the company’s stock valued at $395,000 after buying an additional 130 shares in the last quarter. Sei Investments Co. boosted its position in shares of Mylan N.V. by 1.0% in the first quarter. Sei Investments Co. now owns 13,870 shares of the company’s stock valued at $541,000 after buying an additional 134 shares in the last quarter. Bank of Nova Scotia boosted its position in shares of Mylan N.V. by 1.9% in the first quarter. Bank of Nova Scotia now owns 10,525 shares of the company’s stock valued at $410,000 after buying an additional 196 shares in the last quarter. Finally, Wade G W & Inc. boosted its position in shares of Mylan N.V. by 3.6% in the first quarter. Wade G W & Inc. now owns 6,156 shares of the company’s stock valued at $240,000 after buying an additional 213 shares in the last quarter. Institutional investors own 71.57% of the company’s stock.

Shares of Mylan N.V. (NASDAQ MYL) opened at 30.53 on Friday. Mylan N.V. has a 12 month low of $29.39 and a 12 month high of $45.87. The stock has a market cap of $16.37 billion, a price-to-earnings ratio of 24.68 and a beta of 1.27. The firm has a 50-day moving average price of $35.07 and a 200-day moving average price of $38.49.

Mylan N.V. (NASDAQ:MYL) last released its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.18 by $0.08. The firm had revenue of $2.96 billion for the quarter, compared to analyst estimates of $3 billion. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The firm’s revenue was up 15.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.16 EPS. Equities analysts expect that Mylan N.V. will post $4.52 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Mylan N.V. (MYL) Shares Bought by Comerica Bank” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/08/27/mylan-n-v-myl-shares-bought-by-comerica-bank.html.

MYL has been the topic of several recent research reports. Zacks Investment Research upgraded Mylan N.V. from a “sell” rating to a “hold” rating in a report on Tuesday, August 1st. Barclays PLC upgraded Mylan N.V. from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $47.00 to $50.00 in a report on Monday, May 22nd. Royal Bank Of Canada set a $41.00 target price on Mylan N.V. and gave the stock a “hold” rating in a report on Sunday, July 16th. Citigroup Inc. upgraded Mylan N.V. from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $36.00 to $42.00 in a report on Wednesday, August 16th. Finally, Cowen and Company restated a “market perform” rating and set a $43.00 target price (down from $55.00) on shares of Mylan N.V. in a report on Sunday, May 21st. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $43.43.

In other Mylan N.V. news, President Rajiv Malik sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $1,000,000.00. Following the transaction, the president now owns 799,855 shares in the company, valued at approximately $31,994,200. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Anthony Mauro sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $400,000.00. Following the completion of the transaction, the insider now owns 140,653 shares in the company, valued at approximately $5,626,120. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by corporate insiders.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan N.V. (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan N.V. (NASDAQ:MYL)

Receive News & Stock Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related stocks with our FREE daily email newsletter.